Actinium Pharmaceuticals Inc (ATNM)

Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	35.00	-	-	0.09	-
	25.95%7.44	5.90	6.41	5.78	7.50
Research and Development	27.99%5.38	4.20	4.30	4.25	4.88
Operating Income/Loss	566.97%27.57	-5.90	-6.41	-5.69	-7.50
Nonoperating Income/Loss	11.81%0.34	0.38	0.47	0.56	0.63
	605.27%27.90	-5.52	-5.94	-5.13	-6.88
Attributable To Parent	605.27%27.90	-5.52	-5.94	-5.13	-6.88
Basic Average Shares	0.52%31.40	31.24	-	31.20	31.20
Diluted Average Shares	0.54%31.41	31.24	-	31.20	31.20
Basic Earnings Per Share	594.44%0.89	-0.18	-	-0.16	-0.22
Diluted Earnings Per Share	594.44%0.89	-0.18	-	-0.16	-0.22